Teams led by Bio21's Prof Michael Parker and Prof Karlheinz Peter, Baker in the new Department of Cardiometabolic Health are developing a new anti-inflammatory drug.

Congratulations to Bio21's David Jones, whose research to improve the efficiency of solar cells has been supported by a $1.29 million grant from the Australian Renewable Energy Agency (ARENA).

Bio21's Professor Phil Batterham and Dr Felipe Martelli's PNAS study shows the insecticide Imidacloprid is harmful to insects even at very low doses.

University of Melbourne Associate Professor David Ascher and his team at the Bio21 Molecular Science and Biotechnology Institute and the Baker Heart and Diabetes Institute developed the software tool and library, dubbed COVID-3D.

Liz is funded to show how factors that repair DNA enter the nuclei of living cells using fluorescence microscopy techniques.

Bio21 will play a major role in housing many of the CryoEM microscopes included in the ARC Industrial Transformation Training Centre.

Here we ask Bio21's Associate Professor Stuart Ralph and Dr Craig Morton from University of Melbourne’s School of Biomedical Sciences to explain how anti-viral drugs work and go through the different drug candidates that may help treat COVID-19.

Bio21's Nancy Endersby, Qiong Yang, Tom Schmidt and Ary Hoffmann have investigated patterns of movement of the two resistance profiles for dengue spreading mozzies and the red-legged earth mite.

Mushrooms are some of nature's mightiest recyclers, breaking down glycosidic bonds that hold carbohydrate chains together.

Congratulations to Michael Parker, Eric Reynolds and Debnath Ghosal, who received NHMRC Investigator grant funding.